telmisartan has been researched along with Osteoporosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bilen, A; Celik, M; Celik, Z; Gulaboglu, M; Halici, Z; Kul, A; Kutlu, Z; Maman, A | 1 |
| Birocale, AM; Bissoli, NS; Costalonga Oliveira, PW; Ferreira de Melo, A; Gonçalves Ruffoni, LD; Martins de Oliveira, J; Nogueira, BV; Nonaka, KO; Peixoto, P; Rodrigues Pereira, RM; Takayama, LM | 1 |
2 other study(ies) available for telmisartan and Osteoporosis
| Article | Year |
|---|---|
The relationship of telmisartan with sclerostin in the osteoporosis model induced by ovariectomy in rats.
Topics: Adaptor Proteins, Signal Transducing; Alkaline Phosphatase; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Bone Density; Bone Density Conservation Agents; Bone Morphogenetic Proteins; Disease Models, Animal; Estrogens; Female; Genetic Markers; Osteocalcin; Osteogenesis; Osteopontin; Osteoporosis; Ovariectomy; Rats, Sprague-Dawley; Receptors, Angiotensin; RNA, Messenger; Tartrate-Resistant Acid Phosphatase; Telmisartan | 2021 |
Telmisartan use in rats with preexisting osteoporotics bone disorders increases bone microarchitecture alterations via PPARγ.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Bone Density; Bone Diseases; Cancellous Bone; Female; Gene Expression Regulation; Osteoporosis; PPAR gamma; Rats; Rats, Inbred SHR; Telmisartan; Tomography, X-Ray Computed | 2019 |